ArticleJournal of medicine and life2023

Development of a cost-effective quantitative in-house ELISA assay for screening anti-S1 IgG antibodies targeting SARS-CoV-2.

Abdul-Sattar Al-Saeedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.